Yıl: 2020 Cilt: 54 Sayı: 1 Sayfa Aralığı: 25 - 28 Metin Dili: Türkçe DOI: 10.4274/turkderm.galenos.2019.22567 İndeks Tarihi: 29-07-2022

Diabetes mellituslu bir olguda edinsel perforan dermatozun dev varyantı

Öz:
Perforan dermatozlar, kollajen, elastin, fibrin gibi dermal bileşenlerin transepidermal eliminasyonu ile karakterize bir grup hastalıktır. Perforandermatozlar primer olarak reaktif perforan kollajenöz, elastozis perforans serpiginoza, perforan folikülit ve edinsel perforan dermatoz olmaküzere dört ana hastalık formunu kapsar. Perforan dermatozlarla ilgili literatürde az sayıda bilgi mevcuttur. Nadir görülmelerinden ötürü kolaylıkladikkatten kaçabilmektedirler. Edinsel perforan dermatoz, özellikle diyabet, kronik böbrek yetmezliği gibi sistemik bir hastalığı olup kaşıntılıpapülonodülleri, merkezi kraterli dev plakları olan hastalarda akla gelmelidir. Bu hastalarda öncelikli olarak alta yatan hastalığın tedavisine ekolarak dar bant Ultraviyole B’nin (dbUVB) etkili olabildiğini düşünmekteyiz. Biz de oldukça nadir görülmesi nedeniyle, dbUVB ile tedavi ettiğimiz,kollajen lif eliminasyon paterninin hakim olduğu dev lezyonlu bir edinsel perforan dermatoz olgusunu sunduk.
Anahtar Kelime:

Giant variant of acquired perforating dermatosis in a patient with diabetes mellitus

Öz:
Perforating dermatoses are a group of diseases characterized by transepidermal elimination of dermal components such as collagen, elastin and fibrin. Perforating dermatoses primarily include four main forms: Reactive perforating collagenosis, elastosis perforans serpiginosa, perforating folliculitis and acquired perforating dermatosis. There is limited data about perforating dermatoses in the literature. Because of their rare appearance, they can be easily misdiagnosed. Acquired perforating dermatosis is a systemic disease such as diabetes and chronic renal failure; and it should be considered in case of pruritic papulonodules and giant plaques with central crater in a patient. In addition to the treatment of underlying disease in the first stage; narrow band ultraviolet B (nbUVB) is evaluated to be effective in these cases. Based on its rare occasions, we submit a giant variant of acquired perforating dermatosis with a collagen fiber predominant elimination pattern, which is treated with nbUVB.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Olgu Sunumu Erişim Türü: Erişime Açık
  • Farrell AM: Acquired perforating dermatosis in renal and diabetic patients. Lancet 1997;349:895-6.
  • Garcia-Malinis AJ, Del Valle Sanchez E, Sanchez-Salas MP, Del Prado E, Coscojuela C, Gilaberte Y: Acquired perforating dermatosis: clinicopathological study of 31 cases, emphasizing pathogenesis and treatment. J Eur Acad Dermatol Venereol 2017;31:1757-63.
  • Metterle L, Magro CM, Zang JB: Giant variant of acquired perforating dermatosis in a renal dialysis patient. JAAD Case Rep 2017;3:42-4.
  • Zelger B, Hintner H, Auböck J, Fritsch PO: Acquired perforating dermatosis. Transepidermal elimination of DNA material and possible role of leukocytes in pathogenesis. Arch Dermatol 1991;127:695-700. Alyahya GA, Heegaard S, Prause JU: Ocular changes in a case of Kyrle’s disease. 20-year follow-up. Acta Ophthalmol Scand 2000;78:585-9.
  • Saray Y, Seçkin D, Bilezikçi B: Acquired perforating dermatosis: Clinicopathological features in twenty-two cases. J Eur Acad Dermatol Venereol 2006;20:679-88.
  • Hoque SR, Ameen M, Holden CA: Acquired reactive perforating collagenosis: Four patients with a giant variant treated with allopurinol. Br J Dermatol 2006;154:759-62.
  • Ohe S, Danno K, Sasaki H, Isei T, Okamoto H, Horio T: Treatment of acquired perforating dermatosis with narrowband ultraviolet B. J Am Acad Dermatol 2004;50:892-4.
  • Gnanaraj P, Venugopal V, Sangitha C, Rajagopalan V, Pandurangan CN: A giant variant of acquired reactive perforating collagenosis associated with hydronephrosis: successful treatment with allopurinol. Int J Dermatol 2009;48:204-6.
  • Razmi TM, Chatterjee D, Parsad D: Giant variant of acquired reactive perforating collagenosis in diabetic nephropathy. Postgrad Med J 2019;95:52-3.
  • Kim SW, Kim MS, Lee JH, et al: A clinicopathologic study of thirty cases of acquired perforating dermatosis in Korea. Ann Dermatol 2014;26:162-71.
  • Lee YS, Vijayasingam S, Tan YO, Wong ST: Acquired perforating dermatosis associated with recurrent hepatocellular carcinoma. Int J Dermatol 1996;35:743-5.
  • Pedragosa R, Knobel HJ, Huguet P, Oristrell J, Valdes M, Bosch JA: Reactive perforating collagenosis in Hodgkin's disease. Am J Dermatopathol 1987;9:41-4.
  • Ruiz Villaverde R, Martin Sanchez MC, Blasco Melguizo J, Naranjo Sintes R: [Reactive perforating collagenosis and colon carcinoma]. Rev Clin Esp 2002;202:298-9.
  • Karpouzis A, Tsatalas C, Sivridis E, et al: Acquired reactive perforating collagenosis associated with myelodysplastic syndrome evolving to acute myelogenous leukaemia. Australas J Dermatol 2004;45:78-9.
  • Fatani MI, Al-Ghamdi YM, Al-Afif KA, Abdulghani MR, Karima TM: Acquired reactive perforating collagenosis associated with sick euthyroid syndrome. Saudi Med J 2002;23:1408-10.
  • Faver IR, Daoud MS, Su WP: Acquired reactive perforating collagenosis. Report of six cases and review of the literature. J Am Acad Dermatol 1994;30:575-80.
  • Bank DE, Cohen PR, Kohn SR: Reactive perforating collagenosis in a setting of double disaster: Acquired immunodeficiency syndrome and end-stage renal disease. J Am Acad Dermatol 1989;21:371-4.
  • Kim JH, Kang WH: Acquired reactive perforating collagenosis in a diabetic patient with pulmonary aspergillosis. Cutis 2000;66:425-30.
  • Ohashi T, Yamamoto T. Acquired reactive perforating collagenosis associated with systemic lupus erythematosus. J Dermatol 2016;43:1097-9.
  • Amano H, Nagai Y, Kishi C, Ishikawa O: Acquired reactive perforating collagenosis in dermatomyositis. J Dermatol 2011;38:1199-201.
  • Kurschat P, Kröger A, Scharffetter-Kochanek K, Hunzelmann N: Acquired reactive perforating collagenosis triggered by scabies infection. Acta Derm Venereol 2000;80:384-5.
  • Fistarol SK, Itin PH: Acquired perforating dermatosis in a patient with Poland syndrome. Dermatology 2003;207:390-4.
APA Özçelik S, doğan y, Kılıç A, Lebe B (2020). Diabetes mellituslu bir olguda edinsel perforan dermatozun dev varyantı. , 25 - 28. 10.4274/turkderm.galenos.2019.22567
Chicago Özçelik Sinan,doğan yusuf,Kılıç Arzu,Lebe Banu Diabetes mellituslu bir olguda edinsel perforan dermatozun dev varyantı. (2020): 25 - 28. 10.4274/turkderm.galenos.2019.22567
MLA Özçelik Sinan,doğan yusuf,Kılıç Arzu,Lebe Banu Diabetes mellituslu bir olguda edinsel perforan dermatozun dev varyantı. , 2020, ss.25 - 28. 10.4274/turkderm.galenos.2019.22567
AMA Özçelik S,doğan y,Kılıç A,Lebe B Diabetes mellituslu bir olguda edinsel perforan dermatozun dev varyantı. . 2020; 25 - 28. 10.4274/turkderm.galenos.2019.22567
Vancouver Özçelik S,doğan y,Kılıç A,Lebe B Diabetes mellituslu bir olguda edinsel perforan dermatozun dev varyantı. . 2020; 25 - 28. 10.4274/turkderm.galenos.2019.22567
IEEE Özçelik S,doğan y,Kılıç A,Lebe B "Diabetes mellituslu bir olguda edinsel perforan dermatozun dev varyantı." , ss.25 - 28, 2020. 10.4274/turkderm.galenos.2019.22567
ISNAD Özçelik, Sinan vd. "Diabetes mellituslu bir olguda edinsel perforan dermatozun dev varyantı". (2020), 25-28. https://doi.org/10.4274/turkderm.galenos.2019.22567
APA Özçelik S, doğan y, Kılıç A, Lebe B (2020). Diabetes mellituslu bir olguda edinsel perforan dermatozun dev varyantı. Türkderm Türk deri hastalıkları ve frengi arşivi, 54(1), 25 - 28. 10.4274/turkderm.galenos.2019.22567
Chicago Özçelik Sinan,doğan yusuf,Kılıç Arzu,Lebe Banu Diabetes mellituslu bir olguda edinsel perforan dermatozun dev varyantı. Türkderm Türk deri hastalıkları ve frengi arşivi 54, no.1 (2020): 25 - 28. 10.4274/turkderm.galenos.2019.22567
MLA Özçelik Sinan,doğan yusuf,Kılıç Arzu,Lebe Banu Diabetes mellituslu bir olguda edinsel perforan dermatozun dev varyantı. Türkderm Türk deri hastalıkları ve frengi arşivi, vol.54, no.1, 2020, ss.25 - 28. 10.4274/turkderm.galenos.2019.22567
AMA Özçelik S,doğan y,Kılıç A,Lebe B Diabetes mellituslu bir olguda edinsel perforan dermatozun dev varyantı. Türkderm Türk deri hastalıkları ve frengi arşivi. 2020; 54(1): 25 - 28. 10.4274/turkderm.galenos.2019.22567
Vancouver Özçelik S,doğan y,Kılıç A,Lebe B Diabetes mellituslu bir olguda edinsel perforan dermatozun dev varyantı. Türkderm Türk deri hastalıkları ve frengi arşivi. 2020; 54(1): 25 - 28. 10.4274/turkderm.galenos.2019.22567
IEEE Özçelik S,doğan y,Kılıç A,Lebe B "Diabetes mellituslu bir olguda edinsel perforan dermatozun dev varyantı." Türkderm Türk deri hastalıkları ve frengi arşivi, 54, ss.25 - 28, 2020. 10.4274/turkderm.galenos.2019.22567
ISNAD Özçelik, Sinan vd. "Diabetes mellituslu bir olguda edinsel perforan dermatozun dev varyantı". Türkderm Türk deri hastalıkları ve frengi arşivi 54/1 (2020), 25-28. https://doi.org/10.4274/turkderm.galenos.2019.22567